APA (7th ed.) Citation

Y, J., J, X., I, K., P, S., Q, L., T, O., . . . X, J. (2026). Multi-omics integration provides biological insight and prioritizes potential drug targets in multiple sclerosis progression. Journal of neuroinflammation, 23(1), . https://doi.org/10.1186/s12974-026-03895-z

Chicago Style (17th ed.) Citation

Y, Jiang, Xiao J, Kockum I, Stridh P, Liu Q, Olsson T, Alfredsson L, and Jiang X. "Multi-omics Integration Provides Biological Insight and Prioritizes Potential Drug Targets in Multiple Sclerosis Progression." Journal of Neuroinflammation 23, no. 1 (2026). https://doi.org/10.1186/s12974-026-03895-z.

MLA (9th ed.) Citation

Y, Jiang, et al. "Multi-omics Integration Provides Biological Insight and Prioritizes Potential Drug Targets in Multiple Sclerosis Progression." Journal of Neuroinflammation, vol. 23, no. 1, 2026, https://doi.org/10.1186/s12974-026-03895-z.